(Yicai Global) Nov. 14 -- The medical treatment artificial intelligence (AI) company Deepwise Technology Co. completed its A+ round of financing, bringing the total A-round financing amount to CNY 150 million (USD22.5 million).
The A+ round of financing is led by Danhua Capital and followed by Dalton Venture and Kinzon Capital, among others. The company secured CNY35 million during its A round of financing last September, but it did not reveal the latest valuation after the A+ round, 36kr.com reported yesterday.
Founded in early 2017, with the core patented technology of deep AI learning, Deepwise Technology engages in the development of artificial intelligence medical application products for early disease screening and diagnoses. At present, its main products include intelligent auxiliary diagnosis system, artificial intelligence medical platform, and cloud intelligent auxiliary diagnosis system.
Its products are currently applied for clinical trials in many hospitals and institutions.